Possible drug candidates for Alzheimer's disease deduced from studying their binding interactions with α7 nicotinic acetylcholine receptor

Ruo Xu Gu, Hui Gu, Zhi Yuan Xie, Jing Fang Wang, Hugo R. Arias, Dong Qing Wei, Kuo Chen Chou

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

Dysfunction in α7 nicotinic acetylcholine receptor (nAChR), a member of the Cys-loop ligand-gated ion channel superfamily, is responsible for attentional and cognitive deficits in Alzheimer's disease (AD). To provide useful information for finding drug candidates for the treatment of AD, a study was carried out according to the following procedures. (1) DMXBA, a partial agonist of the α7 nAChR, was used as a template molecule. (2) To reduce the number of compounds to be considered, the similarity search and flexible alignment were conducted to exclude those molecules which did not match the template. (3) The molecules thus obtained were docked to α7 nAChR. (4) To gain more structural information, the molecular dynamics (MD) simulations were carried out for 9 most favorable agonists obtained by the aforementioned docking studies. (5) By analyzing the hydrogen bond interaction and hydrophobic/hydrophilic interaction, the following seven compounds were singled out as possible drug candidates for AD therapy: gx-50, gx-51, gx-52, gx-180, open3d-99008, open3d-51265, open3d-60247.

Original languageEnglish
Pages (from-to)250-262
Number of pages13
JournalMedicinal Chemistry
Volume5
Issue number3
DOIs
StatePublished - 18 Sep 2009
Externally publishedYes

Fingerprint

Nicotinic Receptors
Alzheimer Disease
Pharmaceutical Preparations
Ligand-Gated Ion Channels
Molecular Dynamics Simulation
Hydrophobic and Hydrophilic Interactions
Hydrogen
Therapeutics

Keywords

  • α7 nAChR
  • Chemical modification
  • DMXBA
  • Docking
  • MD simulation

Cite this

Gu, Ruo Xu ; Gu, Hui ; Xie, Zhi Yuan ; Wang, Jing Fang ; Arias, Hugo R. ; Wei, Dong Qing ; Chou, Kuo Chen. / Possible drug candidates for Alzheimer's disease deduced from studying their binding interactions with α7 nicotinic acetylcholine receptor. In: Medicinal Chemistry. 2009 ; Vol. 5, No. 3. pp. 250-262.
@article{adf04290d536497788cf2a0d2c2c772b,
title = "Possible drug candidates for Alzheimer's disease deduced from studying their binding interactions with α7 nicotinic acetylcholine receptor",
abstract = "Dysfunction in α7 nicotinic acetylcholine receptor (nAChR), a member of the Cys-loop ligand-gated ion channel superfamily, is responsible for attentional and cognitive deficits in Alzheimer's disease (AD). To provide useful information for finding drug candidates for the treatment of AD, a study was carried out according to the following procedures. (1) DMXBA, a partial agonist of the α7 nAChR, was used as a template molecule. (2) To reduce the number of compounds to be considered, the similarity search and flexible alignment were conducted to exclude those molecules which did not match the template. (3) The molecules thus obtained were docked to α7 nAChR. (4) To gain more structural information, the molecular dynamics (MD) simulations were carried out for 9 most favorable agonists obtained by the aforementioned docking studies. (5) By analyzing the hydrogen bond interaction and hydrophobic/hydrophilic interaction, the following seven compounds were singled out as possible drug candidates for AD therapy: gx-50, gx-51, gx-52, gx-180, open3d-99008, open3d-51265, open3d-60247.",
keywords = "α7 nAChR, Chemical modification, DMXBA, Docking, MD simulation",
author = "Gu, {Ruo Xu} and Hui Gu and Xie, {Zhi Yuan} and Wang, {Jing Fang} and Arias, {Hugo R.} and Wei, {Dong Qing} and Chou, {Kuo Chen}",
year = "2009",
month = "9",
day = "18",
doi = "10.2174/157340609788185909",
language = "English",
volume = "5",
pages = "250--262",
journal = "Medicinal Chemistry",
issn = "1573-4064",
number = "3",

}

Possible drug candidates for Alzheimer's disease deduced from studying their binding interactions with α7 nicotinic acetylcholine receptor. / Gu, Ruo Xu; Gu, Hui; Xie, Zhi Yuan; Wang, Jing Fang; Arias, Hugo R.; Wei, Dong Qing; Chou, Kuo Chen.

In: Medicinal Chemistry, Vol. 5, No. 3, 18.09.2009, p. 250-262.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Possible drug candidates for Alzheimer's disease deduced from studying their binding interactions with α7 nicotinic acetylcholine receptor

AU - Gu, Ruo Xu

AU - Gu, Hui

AU - Xie, Zhi Yuan

AU - Wang, Jing Fang

AU - Arias, Hugo R.

AU - Wei, Dong Qing

AU - Chou, Kuo Chen

PY - 2009/9/18

Y1 - 2009/9/18

N2 - Dysfunction in α7 nicotinic acetylcholine receptor (nAChR), a member of the Cys-loop ligand-gated ion channel superfamily, is responsible for attentional and cognitive deficits in Alzheimer's disease (AD). To provide useful information for finding drug candidates for the treatment of AD, a study was carried out according to the following procedures. (1) DMXBA, a partial agonist of the α7 nAChR, was used as a template molecule. (2) To reduce the number of compounds to be considered, the similarity search and flexible alignment were conducted to exclude those molecules which did not match the template. (3) The molecules thus obtained were docked to α7 nAChR. (4) To gain more structural information, the molecular dynamics (MD) simulations were carried out for 9 most favorable agonists obtained by the aforementioned docking studies. (5) By analyzing the hydrogen bond interaction and hydrophobic/hydrophilic interaction, the following seven compounds were singled out as possible drug candidates for AD therapy: gx-50, gx-51, gx-52, gx-180, open3d-99008, open3d-51265, open3d-60247.

AB - Dysfunction in α7 nicotinic acetylcholine receptor (nAChR), a member of the Cys-loop ligand-gated ion channel superfamily, is responsible for attentional and cognitive deficits in Alzheimer's disease (AD). To provide useful information for finding drug candidates for the treatment of AD, a study was carried out according to the following procedures. (1) DMXBA, a partial agonist of the α7 nAChR, was used as a template molecule. (2) To reduce the number of compounds to be considered, the similarity search and flexible alignment were conducted to exclude those molecules which did not match the template. (3) The molecules thus obtained were docked to α7 nAChR. (4) To gain more structural information, the molecular dynamics (MD) simulations were carried out for 9 most favorable agonists obtained by the aforementioned docking studies. (5) By analyzing the hydrogen bond interaction and hydrophobic/hydrophilic interaction, the following seven compounds were singled out as possible drug candidates for AD therapy: gx-50, gx-51, gx-52, gx-180, open3d-99008, open3d-51265, open3d-60247.

KW - α7 nAChR

KW - Chemical modification

KW - DMXBA

KW - Docking

KW - MD simulation

UR - http://www.scopus.com/inward/record.url?scp=67651180849&partnerID=8YFLogxK

U2 - 10.2174/157340609788185909

DO - 10.2174/157340609788185909

M3 - Article

C2 - 19442215

AN - SCOPUS:67651180849

VL - 5

SP - 250

EP - 262

JO - Medicinal Chemistry

JF - Medicinal Chemistry

SN - 1573-4064

IS - 3

ER -